Navigation Links
Elsevier acquires oncology journal portfolio from Cancer Information Group
Date:2/2/2011

New York, 2 February, 2011 - Elsevier (www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today that it acquired the oncology portfolio of journals previously published by CIG Media Group LP., (operated as Cancer Information Group). The journals publish peer-reviewed, disease specific original research and review articles that disseminate cutting-edge data to physicians, medical researchers and health care professionals.

"These journals provide an excellent addition to Elsevier's oncology portfolio and will further enhance the depth and quality of oncology content published by Elsevier," said Glen P. Campbell, Executive Vice President, Global Medical Research, for Elsevier. "We look forward to working with the editorial teams and to leveraging Elsevier's global resources and market-leading online platforms for the continued development and growth of the quality, international profile and visibility of these prestigious journals."

The specific journal titles are: Clinical Breast Cancer, Clinical Lung Cancer, Clinical Lymphoma Myeloma & Leukemia, Clinical Colorectal Cancer, Clinical Ovarian Cancer, and Clinical Genitourinary Cancer.

"Authors will benefit from the upcoming release of enhanced online manuscript submission and review systems for the journals, as well as the range of author support tools provided by Elsevier," said Campbell.


'/>"/>

Contact: Tom Reller
T.Reller@elsevier.com
215-239-3508
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. Elsevier Foundation announces 2010 grants for libraries in developing countries
2. Elsevier launches innovative online radiology board review product
3. Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
4. Elsevier/MC Strategies and AORN launch perioperative nursing skills collection
5. Elseviers BrainNavigator 3.0 reflects the next step in enhancing neurological research
6. Elsevier launches new journal: Developmental Cognitive Neuroscience
7. Elsevier introduces SciVerse, an innovative platform for accelerating science
8. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
9. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
10. Elsevier partners with Helinet to strengthen consortiums leadership in health sciences education
11. Elsevier partners with ASRT to provide multimedia educational modules through Mosbys Imaging Suite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Tasting Event at the La Gorce Country Club in Miami Beach on March ...
(Date:2/5/2016)... ... 2016 , ... Regular gym users know the routine: each January, they see ... the treadmills. It’s a predictable trend. After the excesses of November and December, people ... by joining gyms, starting new walking or running routines, or signing up for Zumba. ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... (APDA) announced the election of Patrick McDermott as Chairman of the National Board of ... welcome Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... ... Move from on one drop zone to the next using Colorize's dynamic moving camera. ... any project. This package includes a 3D slideshow environment with 1 to 5 focus ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... for Patients with Rare Diseases, a continuing medical education (CME) event presented by ... first of its kind—and a first for ACCORD, whose mission is to provide ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Summary ... common cancer and the most common cancer in women ... the disease exceedingly prevalent. The number of women diagnosed ... decades, but the number of deaths has declined due ... cancer treatment has been revolutionized in the past four ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
Breaking Medicine Technology: